X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22173) 22173
Newsletter (7973) 7973
Book Review (4261) 4261
Publication (905) 905
Magazine Article (159) 159
Newspaper Article (122) 122
Conference Proceeding (87) 87
Book / eBook (68) 68
Book Chapter (59) 59
Trade Publication Article (53) 53
Web Resource (16) 16
Dissertation (13) 13
Reference (4) 4
Paper (3) 3
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18642) 18642
index medicus (18613) 18613
thrombolytic therapy (12662) 12662
thrombolytic drugs (11519) 11519
male (10083) 10083
female (9380) 9380
middle aged (7824) 7824
aged (7207) 7207
myocardial infarction - drug therapy (5264) 5264
research (5199) 5199
treatment outcome (4963) 4963
abridged index medicus (4592) 4592
fibrinolytic agents - therapeutic use (4549) 4549
stroke (4298) 4298
thrombolytic therapy - methods (4221) 4221
cardiac & cardiovascular systems (3851) 3851
adult (3801) 3801
tissue plasminogen activator - therapeutic use (3792) 3792
thrombolysis (3662) 3662
reports (3568) 3568
time factors (3462) 3462
peripheral vascular disease (3372) 3372
universities and colleges (3252) 3252
care and treatment (3247) 3247
stroke - drug therapy (3164) 3164
risk factors (2863) 2863
clinical neurology (2675) 2675
aged, 80 and over (2613) 2613
drugs (2453) 2453
fibrinolytic agents - administration & dosage (2383) 2383
medical research (2355) 2355
heart attack (2285) 2285
therapy (2282) 2282
thrombosis (2203) 2203
thrombolytic therapy - adverse effects (2196) 2196
drug therapy (2149) 2149
tissue plasminogen activator - administration & dosage (2121) 2121
mortality (2001) 2001
medicine, experimental (1999) 1999
retrospective studies (1995) 1995
tissue plasminogen activator (1921) 1921
medicine, general & internal (1901) 1901
animals (1848) 1848
acute myocardial-infarction (1794) 1794
acute disease (1766) 1766
analysis (1753) 1753
brain ischemia - drug therapy (1686) 1686
prognosis (1682) 1682
myocardial infarction - therapy (1675) 1675
myocardial infarction - mortality (1616) 1616
prospective studies (1607) 1607
acute ischemic-stroke (1575) 1575
tissue-plasminogen activator (1554) 1554
electrocardiography (1536) 1536
surgery (1488) 1488
health aspects (1464) 1464
streptokinase - therapeutic use (1458) 1458
anticoagulants - therapeutic use (1420) 1420
fibrinolytic agents - adverse effects (1404) 1404
follow-up studies (1383) 1383
trial (1383) 1383
ischemia (1381) 1381
thrombosis - drug therapy (1371) 1371
hematology (1313) 1313
heart attacks (1304) 1304
management (1302) 1302
myocardial infarction (1278) 1278
cardiac patients (1263) 1263
anticoagulants (1255) 1255
cardiology (1252) 1252
myocardial infarction - physiopathology (1252) 1252
streptokinase (1143) 1143
angioplasty, balloon, coronary (1136) 1136
neurosciences (1136) 1136
tissue plasminogen activator - adverse effects (1130) 1130
blood clot (1116) 1116
angioplasty (1108) 1108
alteplase (1107) 1107
proteases (1090) 1090
reperfusion (1077) 1077
pulmonary embolism - drug therapy (1039) 1039
urokinase-type plasminogen activator - therapeutic use (1028) 1028
fibrinolysis (1025) 1025
heparin - therapeutic use (1022) 1022
hemorrhage (1014) 1014
recurrence (1012) 1012
infusions, intravenous (1010) 1010
myocardial infarction - diagnosis (1006) 1006
usage (1005) 1005
coronary angiography (987) 987
drug therapy, combination (984) 984
tomography, x-ray computed (960) 960
enzymes (947) 947
recombinant proteins - therapeutic use (904) 904
coronary heart disease (900) 900
randomized controlled trials as topic (898) 898
tissue-plasminogen-activator (890) 890
urokinase (885) 885
medicine & public health (882) 882
platelet aggregation inhibitors - therapeutic use (882) 882
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (44) 44
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - General (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28246) 28246
German (555) 555
French (283) 283
Spanish (211) 211
Russian (201) 201
Japanese (196) 196
Chinese (170) 170
Italian (146) 146
Norwegian (83) 83
Danish (81) 81
Portuguese (72) 72
Polish (69) 69
Swedish (69) 69
Czech (48) 48
Hungarian (44) 44
Dutch (32) 32
Turkish (18) 18
Finnish (16) 16
Serbian (16) 16
Slovak (15) 15
Hebrew (11) 11
Croatian (7) 7
Lithuanian (5) 5
Persian (3) 3
Romanian (3) 3
Slovenian (3) 3
Korean (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 09/2012, Volume 126, Issue 10, pp. 1185 - 1193
Background-Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or... 
atrial fibrillation | percutaneous coronary intervention | triple therapy | myocardial infarction | anticoagulants | antithrombotic treatment | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULATION | HEART RHYTHM ASSOCIATION | RISK | EUROPEAN-SOCIETY | ASPIRIN | CONSENSUS DOCUMENT | STENT IMPLANTATION | DUAL ANTIPLATELET THERAPY | WARFARIN | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARDIOLOGY WORKING GROUP | Myocardial Infarction - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Male | Hemorrhage - prevention & control | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Drug Therapy, Combination - adverse effects | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Atrial Fibrillation - mortality | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - mortality | Platelet Aggregation Inhibitors - adverse effects | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Denmark - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Cohort Studies | Usage | Thrombolytic drugs | Research | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2006, Volume 354, Issue 5, pp. 483 - 495
  At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a stent, often a drug-eluting stent, though most published... 
SLOW-RELEASE | MEDICINE, GENERAL & INTERNAL | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | BARE-METAL | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | BALLOON-EXPANDABLE-STENT | UNPROTECTED LEFT MAIN | SIROLIMUS-ELUTING STENTS | AORTOCORONARY BYPASS GRAFTS | Clinical trials | Heart attacks | Thrombolytic drugs | Drug therapy | Angioplasty | Coronary vessels
Journal Article
Chest, ISSN 0012-3692, 2008, Volume 133, Issue 6, pp. 234S - 256S
This chapter focuses on new antithrombotic drugs that are in phase II or III clinical testing. Development of these new agents was prompted by limitations of... 
Antiplatelet drugs | Anticoagulants | Fibrinolytic agents | Antithrombotic drug | Fibrinolytic Agents - pharmacology | Clinical Trials, Phase III as Topic | Humans | Thrombolytic Therapy | Drugs, Investigational | Evidence-Based Medicine | Clinical Trials, Phase II as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2018, Volume 103, Issue 2, pp. 332 - 340
Journal Article
Journal Article
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, ISSN 0954-4119, 2/2010, Volume 224, Issue 2, pp. 343 - 361
Abstract Ultrasound is a very effective modality for drug delivery and gene therapy because energy that is non-invasively transmitted through the skin can be... 
Microbubble | Transfection | Targeting | Sonoporation | Therapeutic ultrasound | Diagnostic | Drug delivery | Gene therapy | therapeutic ultrasound | sonoporation | GAS-FILLED MICROBUBBLES | ENGINEERING, BIOMEDICAL | transfection | gene therapy | drug delivery | TARGETED MICROBUBBLE DESTRUCTION | BLOOD-BRAIN-BARRIER | targeting | ECHO-CONTRAST AGENTS | PHOSPHOLIPIDS-BASED MICROBUBBLES | ACUTE MYOCARDIAL-INFARCTION | microbubble | INTENSITY FOCUSED ULTRASOUND | CENTRAL-NERVOUS-SYSTEM | diagnostic | CELL-MEMBRANE POROSITY | LOW-FREQUENCY SONOPHORESIS | Electroporation - instrumentation | Sonication - instrumentation | Genetic Therapy - trends | Electroporation - methods | Drug Carriers - chemistry | Sonication - methods | Transfection - trends | Drug Carriers - radiation effects | Transfection - methods | Electroporation - trends | Thrombolytic Therapy - methods | Genetic Therapy - instrumentation | Microbubbles | Sonication - trends | Thrombolytic Therapy - instrumentation | Transfection - instrumentation | Thrombolytic Therapy - trends | Genetic Therapy - methods | Heart | Drugs | Brain | Therapy | Surgical implants | Transcription | Toxicity | Brain tumors | Lung | Genes | Membrane permeability | Rigidity | Tissues | Blood | Biomedical materials | Ultrasonic imaging | Energy | Membrane structures | Efficiency | Cargo capacity | Xenografts | Biocompatibility | Tension | Diffusion | Ultrasound | Repetition | Kidneys | Gene transfer | Human body | Cardiac muscle | Exposure | Permeability | Cavitation | Pressure | Ligands | Skin | Transport processes | Surface tension | Kidney transplantation | Medicine | Biotechnology | Transdermal medication | Index Medicus
Journal Article
Journal Article